Senior insider sale
Chief Medical Officer at TREVI THERAPEUTICS, INC. — senior position signals high conviction
$136.6K
53.37K shares
What this filing means
SCIASCIA THOMAS plans to sell 53.37K shares of TREVI THERAPEUTICS, INC. valued at approximately $136.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/29/2024ACC: 0001972481-24-000130
Officer10% Owner· Chief Medical Officer
Since May 2019
53.37K
Shares to sell
$136.6K
Approx. market value
59.35K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Options
Cash
7/2/2014
59.35KTotal acquired59.35K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/2/2014 | Options Cash | 59.35K | — |
| Total | 59.35K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
53.37K
Market value
$136.6K
5/29/2024
Total
Units
53.37K
Value
$136.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/29/2024 | 53.37K | $136.6K | NASDAQ | Planned |
| Total | 53.37K | $136.6K | ||